DCP Test (Decarboxy Prothrombin PIVKA-II)

A des-gamma-carboxy prothrombin (DCP) test detects levels of a protein induced by liver cancer. Also called the PIVKA-II test, it is used as a tumour marker when hepatocellular carcinoma (HCC) is suspected.

Key features of our DCP test (Decarboxy Prothrombin PIVKA-II):

• DCP is increased in the blood of 70-89% of HCC patients
• Levels may be elevated before imaging tests like CT/MRI reveal a tumour
• Serial testing monitors treatment response and checks for recurrence
• High sensitivity and specificity for hepatocellular carcinoma
• Simple blood draw procedure

Early detection of HCC is crucial for prompt treatment and improved prognosis. Our DCP blood test can diagnose HCC at an early stage when curative treatments are still possible.

Order a DCP test online through our certified labs for screening and monitoring of liver cancer. Receive your results within 1–2 days via email.

#livercancertest #HCC #DCP